BackCabaletta Bio Overview

Cabaletta Bio EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CABA.

Quarterly EBIT

-$44.30M
19.28% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$180.89M
36.73% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)